login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ALPHA TAU MEDICAL LTD -27 (DRTSW) Stock News
USA
- NASDAQ:DRTSW -
0.3448
USD
+0.04 (+13.01%)
Last: 10/21/2025, 8:09:43 PM
Overview
Stock Chart
Technical Analysis
News
DRTSW Latest News, Press Relases and Analysis
All
Press Releases
18 hours ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness
18 hours ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness
2 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial
2 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial
6 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau to Participate in May Investor Conferences
8 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau to Participate in March Investor Conferences
2 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau to Participate in Five September Investor Conferences
2 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces Second Quarter 2025 Financial Results and Provides Corporate Update
5 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau to Present at Jefferies Global Healthcare Conference
5 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update
5 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors
6 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
6 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
ORMP
Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals
7 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma
7 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma
7 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces Full Year 2024 Financial Results and Provides Corporate Update
8 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification
8 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Receives Medical Device Single Audit Program (MDSAP) Certification
9 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease
9 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces FDA Approval of IDE Supplement to Expand Pilot Trial of Alpha DaRT® to Thirty Patients with Pancreatic Cancer in Two Cohorts, with Locally Advanced or Metastatic Disease
9 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day
9 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day
10 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day
10 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day
10 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor
10 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor
10 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference
11 months ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium
a year ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update
a year ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference
a year ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme
a year ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme
a year ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Treats First Patient with Recurrent Lung Cancer
a year ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Treats First Patient with Recurrent Lung Cancer
a year ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
a year ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
a year ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau to Participate in the H.C. Wainwright 26th Annual Global Investment Conference, the Sidoti Small-Cap Virtual Investor Conference, the Redburn Atlantic and Rothschild & Co 2024 Radiopharma Conference, and the Lytham Partners Fall 2024 Investor
a year ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Medical Announces Second Quarter 2024 Financial Results and Provides Corporate Update
a year ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers
a year ago - By: Alpha Tau Medical Ltd.
- Mentions:
DRTS
Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers
Please enable JavaScript to continue using this application.